Serum periostin IDs comorbid chronic rhinosinusitis in asthma

March 21, 2017

(HealthDay)—For patients with asthma, serum periostin is useful for detecting chronic rhinosinusitis with nasal polyps, according to a study published online March 1 in the Annals of the American Thoracic Society.

Takamitsu Asano, M.D., from the Nagoya City University Graduate School of Medical Sciences in Japan, and colleagues examined the utility of serum periostin as a diagnostic biomarker for upper airway disease in with . Sixty-five patients with stable asthma were enrolled: 20 without upper airway disease, 22 with rhinitis, and 23 with (13 with and 10 without nasal polyps). Serum periostin, eotaxin, total immunoglobulin E, fractional exhaled nitric oxide, and blood-sputum eosinophil levels were measured.

The researchers found that patients with asthma with chronic rhinosinusitis had higher serum periostin levels than those without upper airway disease (109.6 ± 47.4 ng/mL versus 83.2 ± 22.9 ng/mL; P = 0.04). Patients with asthma with chronic rhinosinusitis and nasal polyps had higher serum periostin levels than those without nasal polyps (130.0 ± 46.6 ng/mL versus 87.9 ± 37.7 ng/mL; P = 0.001). There was no correlation for serum periostin levels with the presence or severity of rhinitis. Receiver operating curve analyses showed moderate and high diagnostic accuracy for detecting chronic rhinosinusitis and chronic rhinosinusitis with nasal polyps, respectively (area under the curve, 0.71 and 0.86, respectively). Serum periostin was the only biomarker that detected the presence of nasal polyps when comparing patients with comorbid chronic rhinosinusitis and nasal polyps to those without.

"Serum periostin is useful for detecting chronic rhinosinusitis with and predicting radiological chronic rhinosinusitis severity in patients with asthma," the authors write.

The study was funded by research grants from pharmaceutical companies.

Explore further: Patients with severe chronic rhinosinusitis show improvement with Verapamil treatment

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Patients with severe chronic rhinosinusitis show improvement with Verapamil treatment

January 23, 2017
A clinical trial studying the use of Verapamil (a drug currently in use for cardiovascular disease and cluster headache) in alleviating chronic rhinosinusitis (CRS) with nasal polyps revealed significant improvement in the ...

Markers that predict omalizumab response identified

May 2, 2016
(HealthDay)—Baseline serum periostin levels and levels of serum free immunoglobulin E (IgE) during treatment follow-up may be useful in assessing response to omalizumab treatment for asthma, according to a study published ...

Verapamil benefits chronic rhinosinusitis with nasal polyps

January 26, 2017
(HealthDay)—For patients with chronic rhinosinusitis with nasal polyps (CRSwNP), the first-generation inhibitor of epithelial P-glycoprotein (P-gp; an efflux pump that is overexpressed in CRSwNP), verapamil hydrochloride ...

Chronic rhinosinusitis linked to increased risk of other diseases

September 8, 2015
(HealthDay)—Chronic rhinosinusitis (CRS) is associated with increased risk of other diseases, with different patterns based on CRS phenotype, according to research published online Aug. 31 in Allergy.

Free light chains identified in chronic rhinosinusitis

July 16, 2012
(HealthDay) -- Patients with chronic rhinosinusitis (CRS) have increased free light chain (FLC) concentrations, particularly those with CRS with nasal polyps (CRSwNP), according to a study published online July 5 in Allergy.

Immune system blood cell a potential marker for sinus polyp regrowth

June 8, 2016
In an effort to identify a simple, reliable way to track the course of nasal polyps in chronic sinus disease, Johns Hopkins Medicine researchers say they've linked rising levels of immune system white blood cells, called ...

Recommended for you

Study demonstrates new treatment for severe asthma

May 22, 2018
Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton, together with colleagues at other partnering institutions, have developed a new method to treat ...

Eczema drug effective against severe asthma

May 21, 2018
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies. Dupilumab, an injectable ...

Neuron guidance factor found to play a key role in immune cell function

May 21, 2018
Macrophages are white blood cells involved in a variety of biological functions, from destroying infectious pathogens to repairing damaged tissue. To carry out their different roles, macrophages must first be activated and ...

Immune cells hold promise in slowing down ALS

May 21, 2018
Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive ...

First clues to the causes of multiple sclerosis

May 16, 2018
Multiple sclerosis, which affects one in 1,000 people, is frequently characterised by relapses associated with variable functional impairments including among others vision problems, impairment of locomotor functions or difficulties ...

A high-fiber diet protects mice against the flu virus

May 15, 2018
Dietary fiber increases survival in influenza-infected mice by setting the immune system at a healthy level of responsiveness, according to a preclinical study published May 15th in the journal Immunity. A high-fiber diet ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.